Abstract
The authors examined the effects of antipsychotic treatment on cerebrospinal fluid somatostatin like immunoreactivity (CSF SLI) in 14 schizophrenic and 3 schizoaffective patients. There was a modest but significant increase in CSF SLI in 13 out of the 14 schizophrenic patients. In addition, there was a significant positive correlation between duration of treatment and post-treatment CSF SLI concentrations. No differential response was noted in patients also treated with the anticholinergic benztropine.
Original language | English (US) |
---|---|
Pages (from-to) | 173-177 |
Number of pages | 5 |
Journal | Schizophrenia Research |
Volume | 13 |
Issue number | 2 |
DOIs | |
State | Published - Sep 1994 |
Externally published | Yes |
Keywords
- Antipsychotic
- Homovanillic acid
- Somatostatin
ASJC Scopus subject areas
- Psychology(all)
- Psychiatry and Mental health
- Behavioral Neuroscience
- Biological Psychiatry
- Neurology